NADPH oxidases as novel pharmacologic targets against influenza A virus infection

Molecular Pharmacology

Volumn 86, Issue 6, 2014, Pages 747-759

  Vlahos, Ross ^a   Selemidis, Stavros ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; APOCYNIN; DUOX1 PROTEIN; DUOX2 PROTEIN; INFLUENZA VACCINE; ISOENZYME; MEMBRANE PHOSPHOLIPID; OXIDOREDUCTASE INHIBITOR; PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG; CYBB PROTEIN, HUMAN; ENZYME INHIBITOR; MEMBRANE LIPID; MEMBRANE PROTEIN; PHOSPHOLIPID;

AIRWAY CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; DRUG BIOAVAILABILITY; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SUBUNIT; HUMAN; IMMUNOPATHOLOGY; INFECTION PREVENTION; INFLUENZA A; INFLUENZA A VIRUS; LEUKOCYTE MIGRATION INHIBITION; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG INJURY; MACROPHAGE MIGRATION INHIBITION; MAMMAL CELL; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; POLYPHARMACY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; SEQUENCE HOMOLOGY; SHORT SURVEY; VIRUS LOAD; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYMOLOGY; INFLUENZA VIRUS A; INFLUENZA, HUMAN; METABOLISM; PHYSIOLOGY;

ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MACROPHAGES, ALVEOLAR; MEMBRANE GLYCOPROTEINS; MEMBRANE LIPIDS; NADPH OXIDASE; PHOSPHOLIPIDS; REACTIVE OXYGEN SPECIES;

EID: 84921856790     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.095216     Document Type: Short Survey

References (197)

1. Abo A, Pick E, Hall A, Totty N, Teahan CG, and Segal AW (1991) Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353:668-670.
2. Ago T, Kuribayashi F, Hiroaki H, Takeya R, Ito T, Kohda D, and Sumimoto H (2003) Phosphorylation of p47phox directs phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. Proc Natl Acad Sci USA 100:4474-4479.
3. Ago T, Nunoi H, Ito T, and Sumimoto H (1999) Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47(phox): triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J Biol Chem 274:33644-33653.
4. Ago T, Takeya R, Hiroaki H, Kuribayashi F, Ito T, Kohda D, and Sumimoto H (2001) The PX domain as a novel phosphoinositide- binding module. Biochem Biophys Res Commun 287:733-738.
5. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, and Maeda H (1996) Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 93:2448-2453.
6. Alp NJ and Channon KM (2004) Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24:413-420.
7. Ambasta RK, Kumar P, Griendling KK, Schmidt HHHW, Busse R, and Brandes RP (2004) Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279:45935-45941.
8. Ando S, Kaibuchi K, Sasaki T, Hiraoka K, Nishiyama T, Mizuno T, Asada M, Nunoi H, Matsuda I, and Matsuura Y et al. (1992) Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J Biol Chem 267:25709-25713.
9. Babior BM and Kipnes RS (1977) Superoxide-forming enzyme from human neutrophils: evidence for a flavin requirement. Blood 50:517-524.
10. Babior BM, Kipnes RS, and Curnutte JT (1973) Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741-744.
11. Babior BM, Lambeth JD, and Nauseef W (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397:342-344.
12. Baldrigde CW and Gerard RW (1932) The extra respiration of phagocytosis. Am J Physiol 103:235-236.
13. Bánfi B, Clark RA, Steger K, and Krause KH (2003) Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278:3510-3513.
14. Bánfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, and Krause K-H (2004) NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 279:46065-46072.
15. Bánfi B, Maturana A, Jaconi S, Arnaudeau S, Laforge T, Sinha B, Ligeti E, Demaurex N, and Krause KH (2000) A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 287:138-142.
16. Bánfi B, Molnár G, Maturana A, Steger K, Hegedûs B, Demaurex N, and Krause KH (2001) A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 276:37594-37601.
17. Bao J, Sato K, Li M, Gao Y, Abid R, Aird W, Simons M, and Post MJ. (2001). PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated kappa alpha degradation. Am J Physiol Heart Circ Physiol 281(6):H2612-H2618.
18. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624.
19. BelAiba RS, Djordjevic T, Petry A, Diemer K, Bonello S, Banfi B, Hess J, Pogrebniak A, Bickel C, and Görlach A (2007) NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med 42:446-459.
20. Bengtsson SH, Gulluyan LM, Dusting GJ, and Drummond GR (2003) Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin Exp Pharmacol Physiol 30:849-854.
21. Bishop AL and Hall A (2000) Rho GTPases and their effector proteins. Biochem J 348:241-255.
22. Bissonnette SA, Glazier CM, Stewart MQ, Brown GE, Ellson CD, and Yaffe MB (2008) Phosphatidylinositol 3-phosphate-dependent and -independent functions of p40phox in activation of the neutrophil NADPH oxidase. J Biol Chem 283:2108-2119.
23. Bourne HR, Sanders DA, and McCormick F (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348:125-132.
24. Bourne HR, Sanders DA, and McCormick F (1991) The GTPase superfamily: conserved structure and molecular mechanism. Nature 349:117-127.
25. Boveris A and Cadenas E (1975) Mitochondrial production of superoxide anions and its relationship to the antimycin insensitive respiration. FEBS Lett 54:311-314.
26. Brandes RP, Weissmann N, and Schröder K (2010) NADPH oxidases in cardiovascular disease. Free Radic Biol Med 49:687-706.
27. Buffinton GD, Christen S, Peterhans E, and Stocker R (1992) Oxidative stress in lungs of mice infected with influenza A virus. Free Radic Res Commun 16:99-110.
28. Burritt JB, DeLeo FR, McDonald CL, Prigge JR, Dinauer MC, Nakamura M, Nauseef WM, and Jesaitis AJ (2001) Phage display epitope mapping of human neutrophil flavocytochrome b558. Identification of two juxtaposed extracellular domains. J Biol Chem 276:2053-2061.
29. Burritt JB, Foubert TR, Baniulis D, Lord CI, Taylor RM, Mills JS, Baughan TD, Roos D, Parkos CA, and Jesaitis AJ (2003) Functional epitope on human neutrophil flavocytochrome b558. J Immunol 170:6082-6089.
30. Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, Cave AC, and Shah AM (2003) Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93:802-805.
31. Carnesecchi S, Deffert C, Pagano A, Garrido-Urbani S, Métrailler-Ruchonnet I, Schäppi M, Donati Y, Matthay MA, Krause KH, and Barazzone Argiroffo C (2009) NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am J Respir Crit Care Med 180:972-981.
32. Chance B, Sies H, and Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527-605.
33. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD (2001) Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269:131-140.
34. Cheng G, Diebold BA, Hughes Y, and Lambeth JD (2006) Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem 281:17718-17726.
35. Cheng G and Lambeth JD (2004) NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem 279:4737-4742.
36. Cheng G and Lambeth JD (2005) Alternative mRNA splice forms of NOXO1: differential tissue expression and regulation of Nox1 and Nox3. Gene 356:118-126.
37. Clark RA, Volpp BD, Leidal KG, and Nauseef WM (1990) Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest 85:714-721.
38. Csányi G, Cifuentes-Pagano E, Al Ghouleh I, Ranayhossaini DJ, Egaña L, Lopes LR, Jackson HM, Kelley EE, and Pagano PJ (2011) Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radic Biol Med 51:1116-1125.
39. Cui XL, Brockman D, Campos B, and Myatt L (2006) Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27:422-431.
40. Dang PMC, Stensballe A, Boussetta T, Raad H, Dewas C, Kroviarski Y, Hayem G, Jensen ON, Gougerot-Pocidalo MA, and El-Benna J (2006) A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 116:2033-2043.
41. De Leo FR, Ulman KV, Davis AR, Jutila KL, and Quinn MT (1996) Assembly of the human neutrophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox. J Biol Chem 271:17013-17020.
42. de Mendez I, Adams AG, Sokolic RA, Malech HL, and Leto TL (1996) Multiple SH3 domain interactions regulate NADPH oxidase assembly in whole cells. EMBO J 15:1211-1220.
43. de Mendez I, Homayounpour N, and Leto TL (1997) Specificity of p47phox SH3 domain interactions in NADPH oxidase assembly and activation. Mol Cell Biol 17:2177-2185.
44. DeLeo FR, Burritt JB, Yu L, Jesaitis AJ, Dinauer MC, and Nauseef WM (2000) Processing and maturation of flavocytochrome b558 include incorporation of heme as a prerequisite for heterodimer assembly. J Biol Chem 275:13986-13993.
45. DeLeo FR, Nauseef WM, Jesaitis AJ, Burritt JB, Clark RA, and Quinn MT (1995a) A domain of p47phox that interacts with human neutrophil flavocytochrome b558. J Biol Chem 270:26246-26251.
46. DeLeo FR, Yu L, Burritt JB, Loetterle LR, Bond CW, Jesaitis AJ, and Quinn MT (1995b) Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Proc Natl Acad Sci USA 92:7110-7114.
47. Diatchuk V, Lotan O, Koshkin V, Wikstroem P, and Pick E (1997) Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 272:13292-13301.
48. Didsbury JR, Uhing RJ, and Snyderman R (1990) Isoprenylation of the low molecular mass GTP-binding proteins rac 1 and rac 2: possible role in membrane localization. Biochem Biophys Res Commun 171:804-812.
49. Diekmann D, Abo A, Johnston C, Segal AW, and Hall A (1994) Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 265:531-533.
50. Dinauer MC (2003) Regulation of neutrophil function by Rac GTPases. Curr Opin Hematol 10:8-15.
51. Dinauer MC, Pierce EA, Erickson RW, Muhlebach TJ, Messner H, Orkin SH, Seger RA, and Curnutte JT (1991) Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. Proc Natl Acad Sci USA 88:11231-11235.
52. Doherty PC, Turner SJ, Webby RG, and Thomas PG (2006) Influenza and the challenge for immunology. Nat Immunol 7:449-455.
53. Dorseuil O, Quinn MT, Bokoch GM (1995). Dissociation of Rac translocation from p47phox/p67phox movements in human neutrophils by tyrosine kinase inhibitors. J Leukoc Biol 58(1):108-113.
54. Doussière J, Gaillard J, and Vignais PV (1996) Electron transfer across the O2- generating flavocytochrome b of neutrophils: evidence for a transition from a low-spin state to a high-spin state of the heme iron component. Biochemistry 35:13400-13410.
55. Drummond GR, Selemidis S, Griendling KK, and Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453-471.
56. El-Benna J, Dang PMC, and Gougerot-Pocidalo MA (2008) Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol 30:279-289.
57. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, and Braut-Boucher F (2009) p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 41:217-225.
58. El Benna J, Faust RP, Johnson JL, and Babior BM (1996) Phosphorylation of the respiratory burst oxidase subunit p47phox as determined by two-dimensional phosphopeptide mapping. Phosphorylation by protein kinase C, protein kinase A, and a mitogen-activated protein kinase. J Biol Chem 271:6374-6378.
59. Ellson CD, Gobert-Gosse S, Anderson KE, Davidson K, Erdjument-Bromage H, Tempst P, Thuring JW, Cooper MA, Lim ZY, and Holmes AB et al. (2001) PtdIns(3) P regulates the neutrophil oxidase complex by binding to the PX domain of p40 (phox). Nat Cell Biol 3:679-682.
60. Etienne-Manneville S and Hall A (2002) Rho GTPases in cell biology. Nature 420:629-635.
61. Finan P, Shimizu Y, Gout I, Hsuan J, Truong O, Butcher C, Bennett P, Waterfield MD, and Kellie S (1994) An SH3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J Biol Chem 269:13752-13755.
62. Finegold AA, Shatwell KP, Segal AW, Klausner RD, and Dancis A (1996) Intramembrane bis-heme motif for transmembrane electron transport conserved in a yeast iron reductase and the human NADPH oxidase. J Biol Chem 271:31021-31024.
63. Fink K, Duval A, Martel A, Soucy-Faulkner A, and Grandvaux N (2008) Dual role of NOX2 in respiratory syncytial virus- and sendai virus-induced activation of NF-kappaB in airway epithelial cells. J Immunol 180:6911-6922.
64. Fontayne A, Dang PM, Gougerot-Pocidalo MA, and El-Benna J (2002) Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41:7743-7750.
65. Fulton DJ (2009) Nox5 and the regulation of cellular function. Antioxid Redox Signal 11:2443-2452.
66. Geiszt M, Kopp JB, Várnai P, and Leto TL (2000) Identification of renox, an NAD(P) H oxidase in kidney. Proc Natl Acad Sci USA 97:8010-8014.
67. Geiszt M, Lekstrom K, Witta J, and Leto TL (2003) Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem 278:20006-20012.
68. Gorin Y, Ricono JM, Kim N-H, Bhandari B, Choudhury GG, and Abboud HE (2003) Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285:F219-F229.
69. Gorzalczany Y, Alloul N, Sigal N, Weinbaum C, and Pick E (2002) A prenylated p67phox-Rac1 chimera elicits NADPH-dependent superoxide production by phagocyte membranes in the absence of an activator and of p47phox: conversion of a pagan NADPH oxidase to monotheism. J Biol Chem 277:18605-18610.
70. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994). Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148.
71. Griffith B, Pendyala S, Hecker L, Lee PJ, Natarajan V, and Thannickal VJ (2009) NOX enzymes and pulmonary disease. Antioxid Redox Signal 11:2505-2516.
72. Groemping Y, Lapouge K, Smerdon SJ, and Rittinger K (2003) Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell 113:343-355.
73. Groemping Y and Rittinger K (2005) Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J 386:401-416.
74. Haber F and Weiss J (1932) On the catalysis of hydroperoxide. Naturwissenschaften 20:948-950.
75. Han C-H, Freeman JLR, Lee T, Motalebi SA, and Lambeth JD (1998) Regulation of the neutrophil respiratory burst oxidase. Identification of an activation domain in p67(phox). J Biol Chem 273:16663-16668.
76. Hanna IR, Hilenski LL, Dikalova A, Taniyama Y, Dikalov S, Lyle A, Quinn MT, Lassègue B, and Griendling KK (2004) Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med 37:1542-1549.
77. Harper A, Chaplin M, and Segal A (1985). Cytochrome b-245 from human neutrophils is a glycoprotein. Biochem J 227:783-788.
78. Harrison CB, Selemidis S, Guida E, King PT, Sobey CG, and Drummond GR (2012) NOX2β: A novel splice variant of NOX2 that regulates NADPH oxidase activity in macrophages. PLoS ONE 7:e48326.
79. Harrison IP and Selemidis S (2014) Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets. Clin Exp Pharmacol Physiol 41:533-542.
80. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schröder K, and Brandes RP (2008) Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51:211-217.
81. Heyworth PG, Bohl BP, Bokoch GM, and Curnutte JT (1994) Rac translocates independently of the neutrophil NADPH oxidase components p47phox and p67phox: evidence for its interaction with flavocytochrome b558. J Biol Chem 269:30749-30752.
82. Hiroaki H, Ago T, Ito T, Sumimoto H, and Kohda D (2001) Solution structure of the PX domain, a target of the SH3 domain. Nat Struct Biol 8:526-530.
83. Hofstetter A, De La Cruz J, Patel J, McCoy J, Cao W, Kim J, Diebold B, Belser J, Tumpey T, Katz J, et al. (2013). Adverse role of influenza A virus-induced Nox1 in neutralizing antibody responses and survival against lethal viral challenge in mice [Meeting Abstract Supplement]. Immunol 190:57.15.
84. Honbou K, Minakami R, Yuzawa S, Takeya R, Suzuki NN, Kamakura S, Sumimoto H, and Inagaki F (2007) Full-length p40phox structure suggests a basis for regulation mechanism of its membrane binding. EMBO J 26:1176-1186.
85. Hoyal CR, Gutierrez A, Young BM, Catz SD, Lin JH, Tsichlis PN, and Babior BM (2003) Modulation of p47PHOX activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase. Proc Natl Acad Sci USA 100:5130-5135.
86. Huang J, Hitt ND, and Kleinberg ME (1995) Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558. Biochemistry 34:16753-16757.
87. Huang J and Kleinberg ME (1999) Activation of the phagocyte NADPH oxidase protein p47(phox). Phosphorylation controls SH3 domain-dependent binding to p22 (phox). J Biol Chem 274:19731-19737.
88. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, and Wang H, et al. (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133:235-249.
89. Imajoh-Ohmi S, Tokita K, Ochiai H, Nakamura M, and Kanegasaki S (1992) Topology of cytochrome b558 in neutrophil membrane analyzed by anti-peptide antibodies and proteolysis. J Biol Chem 267:180-184.
90. Imlay JA (2008) Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem 77:755-776.
91. Inanami O, Johnson JL, McAdara JK, Benna JE, Faust LRP, Newburger PE, and Babior BM (1998) Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304. J Biol Chem 273:9539-9543.
92. Isogai Y, Iizuka T, and Shiro Y (1995) The mechanism of electron donation to molecular oxygen by phagocytic cytochrome b558. IMAGE J Biol Chem 270:7853-7857.
93. Iyer GYN, Islam DMF, and Quastel JH (1963) Biochemical aspects of phagocytosis. Nature 192:535-542.
94. Jagnandan D, Church JE, Banfi B, Stuehr DJ, Marrero MB, and Fulton DJR (2007) Novel mechanism of activation of NADPH oxidase 5(NOX5): Calcium-sensitization via phosphorylation. J Biol Chem282:6494-6507
95. Kami K, Takeya R, Sumimoto H, and Kohda D (2002). Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p. EMBO J 21:4268-4276.
96. Kanai F, Liu H, Field SJ, Akbary H, Matsuo T, Brown GE, Cantley LC, and Yaffe MB (2001) The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nat Cell Biol 3:675-678.
97. Karathanassis D, Stahelin RV, Bravo J, Perisic O, Pacold CM, Cho W, and Williams RL (2002) Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction. EMBO J 21:5057-5068.
98. Kash JC, Xiao Y, Davis AS, Walters KA, Chertow DS, Easterbrook JD, Dunfee RL, Sandouk A, Jagger BW, and Schwartzman LM et al. (2014) Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice. Free Radic Biol Med 67:235-247.
99. Kawahara T, Kuwano Y, Teshima-Kondo S, Takeya R, Sumimoto H, Kishi K, Tsunawaki S, Hirayama T, and Rokutan K (2004) Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol 172:3051-3058.
100. Kawahara T, Ritsick D, Cheng G, and Lambeth JD (2005) Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J Biol Chem 280:31859-31869.
101. Kinsella BT, Erdman RA, and Maltese WA (1991) Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA. J Biol Chem 266:9786-9794.
102. Kleinberg ME, Rotrosen D, and Malech HL (1989) Asparagine-linked glycosylation of cytochrome b558 large subunit varies in different human phagocytic cells. J Immunol 143:4152-4157.
103. Knaus UG, Heyworth PG, Evans T, Curnutte JT, and Bokoch GM (1991) Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 254:1512-1515.
104. Koga H, Terasawa H, Nunoi H, Takeshige K, Inagaki F, and Sumimoto H (1999) Tetratricopeptide repeat (TPR) motifs of p67(phox) participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J Biol Chem 274:25051-25060.
105. Kreck ML, Freeman JL, Abo A, and Lambeth JD (1996) Membrane association of Rac is required for high activity of the respiratory burst oxidase. Biochemistry 35:15683-15692.
106. Lagente V, Planquois JM, Leclerc O, Schmidlin F, and Bertrand CP (2008) Oxidative stress is an important component of airway inflammation in mice exposed to cigarette smoke or lipopolysaccharide. Clin Exp Pharmacol Physiol 35:601-605.
107. La Gruta NL, Kedzierska K, Stambas J, and Doherty PC (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85:85-92.
108. Lambeth JD, Kawahara T, and Diebold B (2007) Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 43:319-331.
109. Lapouge K, Smith SJM, Walker PA, Gamblin SJ, Smerdon SJ, and Rittinger K (2000) Structure of the TPR domain of p67phox in complex with Rac.GTP. Mol Cell 6:899-907.
110. Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, and Griendling KK (2001) Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888-894.
111. Lazrak A, Iles KE, Liu G, Noah DL, Noah JW, and Matalon S (2009) Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species. FASEB J 23:3829-3842.
112. Leto TL, Adams AG, and de Mendez I (1994) Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. Proc Natl Acad Sci USA 91:10650-10654.
113. Leusen JH, Bolscher BG, Hilarius PM, Weening RS, Kaulfersch W, Seger RA, Roos D, and Verhoeven AJ (1994) 156Pro - >Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med 180:2329-2334.
114. Liao JK (2004) Statin therapy: having the good without the bad. Hypertension 43:1171-1172.
115. Marcoux J, Man P, Petit-Haertlein I, Vivès C, Forest E, and Fieschi F (2010) p47phox molecular activation for assembly of the neutrophil NADPH oxidase complex. J Biol Chem 285:28980-28990.
116. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, and Knaus UG (2006) Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18:69-82.
117. McCord JM and Fridovich I (1968) The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem 243:5753-5760.
118. McPhail LC (1994) SH3-dependent assembly of the phagocyte NADPH oxidase. J Exp Med 180:2011-2015.
119. McPhail LC, DeChatelet LR, and Shirley PS (1976) Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes. J Clin Invest 58:774-780.
120. Mills EL, Debets-Ossenkopp Y, Verbrugh HA, and Verhoef J (1981) Initiation of the respiratory burst of human neutrophils by influenza virus. Infect Immun 32:1200-1205.
121. Miyano K, Ueno N, Takeya R, and Sumimoto H (2006) Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1. J Biol Chem 281:21857-21868.
122. Moscona A (2008) Medical management of influenza infection. Annu Rev Med 59:397-413.
123. Moscona A (2005a) Neuraminidase inhibitors for influenza. N Engl J Med 353:1363-1373.
124. Moscona A (2005b) Oseltamivir resistance: disabling our influenza defenses. N Engl JMed353:2633-2636.
125. Nakamura R, Sumimoto H, Mizuki K, Hata K, Ago T, Kitajima S, Takeshige K, Sakaki Y, and Ito T (1998) The PC motif: a novel and evolutionarily conserved sequence involved in interaction between p40phox and p67phox, SH3 domain-containing cytosolic factors of the phagocyte NADPH oxidase. Eur J Biochem 251:583-589.
126. Nisimoto Y, Freeman JLR, Motalebi SA, Hirshberg M, and Lambeth JD (1997) Rac binding to p67(phox). Structural basis for interactions of the Rac1 effector region and insert region with components of the respiratory burst oxidase. J Biol Chem 272:18834-18841.
127. Nisimoto Y, Motalebi S, Han C-H, and Lambeth JD (1999) The p67(phox) activation domain regulates electron flow from NADPH to flavin in flavocytochrome b(558). J Biol Chem 274:22999-23005.
128. Nobuhisa I, Takeya R, Ogura K, Ueno N, Kohda D, Inagaki F, and Sumimoto H (2006) Activation of the superoxide-producing phagocyte NADPH oxidase requires co-operation between the tandem SH3 domains of p47phox in recognition of a polyproline type II helix and an adjacent alpha-helix of p22phox. Biochem J 396:183-192.
129. Noda Y, Kohjima M, Izaki T, Ota K, Yoshinaga S, Inagaki F, Ito T, and Sumimoto H (2003) Molecular recognition in dimerization between PB1 domains. J Biol Chem 278:43516-43524.
130. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, and Maeda H (1989) Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244:974-976.
131. Opitz N, Drummond GR, Selemidis S, Meurer S, and Schmidt HHHW (2007) The 'A's and 'O's of NADPH oxidase regulation: a commentary on "Subcellular localization and function of alternatively spliced Noxo1 isoforms". Free Radic Biol Med 42:175-179.
132. Orrenius S, Gogvadze V, and Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143-183.
133. Osterholm MT (2005) Preparing for the next pandemic. N Engl J Med 352:1839-1842.
134. Pacher P, Nivorozhkin A, and Szabó C (2006) Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58:87-114.
135. Paclet MH, Henderson LM, Campion Y, Morel F, and Dagher MC (2004) Localization of Nox2 N-terminus using polyclonal antipeptide antibodies. Biochem J 382:981-986.
136. Pandey D and Fulton DJ (2011) Molecular regulation of NADPH oxidase 5 via the MAPK pathway. Am J Physiol Heart Circ Physiol 300:H1336-H1344.
137. Paravicini TM, Gulluyan LM, Dusting GJ, and Drummond GR (2002) Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ Res 91:54-61.
138. Parkos CA, Allen RA, Cochrane CG, and Jesaitis AJ (1987) Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest 80:732-742.
139. Perrone LA, Plowden JK, García-Sastre A, Katz JM, and Tumpey TM (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4:e1000115.
140. Peshavariya H, Dusting GJ, Jiang F, Halmos LR, Sobey CG, Drummond GR, and Selemidis S (2009a) NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch Pharmacol 380:193-204.
141. Peshavariya H, Jiang F, Taylor CJ, Selemidis S, Chang CW, and Dusting GJ (2009b) Translation-linked mRNA destabilization accompanying serum-induced Nox4 expression in human endothelial cells. Antioxid Redox Signal 11:2399-2408.
142. Peshavariya HM, Dusting GJ, and Selemidis S (2007) Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic Res 41:699-712.
143. Ponting CP (1996) Novel domains in NADPH oxidase subunits, sorting nexins, and PtdIns 3-kinases: binding partners of SH3 domains? Protein Sci 5:2353-2357.
144. Rahman I, Biswas SK, and Kode A (2006) Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 533:222-239.
145. Rahman I, Gilmour PS, Jimenez LA, and MacNee W (2002) Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 234-235:239-248.
146. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, and Pagano PJ (2001) Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89:408-414.
147. Ris-Stalpers C (2006) Physiology and pathophysiology of the DUOXes. Antioxid Redox Signal 8:1563-1572.
148. Rossi F and Zatti M (1964) Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 20:21-23.
149. Rotrosen D and Leto TL (1990) Phosphorylation of neutrophil 47-kDa cytosolic oxidase factor. Translocation to membrane is associated with distinct phosphorylation events. J Biol Chem 265:19910-19915.
150. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, and Barford D (2003) Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423:769-773.
151. Sarfstein R, Gorzalczany Y, Mizrahi A, Berdichevsky Y, Molshanski-Mor S, Weinbaum C, Hirshberg M, Dagher MC, and Pick E (2004) Dual role of Rac in the assembly of NADPH oxidase, tethering to the membrane and activation of p67phox: a study based on mutagenesis of p67phox-Rac1 chimeras. J Biol Chem 279:16007-16016.
152. Segal AW (2005) How neutrophils kill microbes. Annu Rev Immunol 23:197-223.
153. Segal AW and Jones OT (1978) Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature 276:515-517.
154. Selemidis S (2008) Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors. Clin Exp Pharmacol Physiol 35:1395-1401.
155. Selemidis S, Dusting GJ, Peshavariya H, Kemp-Harper BK, and Drummond GR (2007) Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res 75:349-358.
156. Selemidis S, Seow HJ, Broughton BR, Vinh A, Bozinovski S, Sobey CG, Drummond GR, and Vlahos R (2013) Nox1 oxidase suppresses influenza a virus-induced lung inflammation and oxidative stress. PLoS ONE 8:e60792.
157. Selemidis S, Sobey CG, Wingler K, Schmidt HH, and Drummond GR (2008) NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120:254-291.
158. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJD, Banerjee A, and Silliman CC (2005) Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol 78:1025-1042.
159. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, and Sumimoto H (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276:1417-1423.
160. Simmons DL, Botting RM, and Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387-437.
161. Snelgrove RJ, Edwards L, Rae AJ, and Hussell T (2006) An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 36:1364-1373.
162. Soucy-Faulkner A, Mukawera E, Fink K, Martel A, Jouan L, Nzengue Y, Lamarre D, Vande Velde C, and Grandvaux N (2010) Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression. PLoS Pathog 6:e1000930.
163. Strengert M, Jennings R, Davanture S, Hayes P, Gabriel G, and Knaus UG (2014) Mucosal reactive oxygen species are required for antiviral response: role of Duox in influenza a virus infection. Antioxid Redox Signal 20:2695-2709.
164. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79-82.
165. Suliman HB, Ryan LK, Bishop L, and Folz RJ (2001) Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. Am J Physiol Lung Cell Mol Physiol 280:L69-L78.
166. Sumimoto H, Kage Y, Nunoi H, Sasaki H, Nose T, Fukumaki Y, Ohno M, Minakami S, and Takeshige K (1994) Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc Natl Acad Sci USA 91:5345-5349.
167. Sumimoto H, Miyano K, and Takeya R (2005) Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 338:677-686.
168. Szabó C, Ischiropoulos H, and Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6:662-680.
169. Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E, Hermann F, Hadenque A, and Krause KH (2005). Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207:164-176.
170. Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, and Aggarwal BB (2003) Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 278:24233-24241.
171. Takemura Y, Goodson P, Bao HF, Jain L, and Helms MN (2010) Rac1-mediated NADPH oxidase release of O2- regulates epithelial sodium channel activity in the alveolar epithelium. Am J Physiol Lung Cell Mol Physiol 298:L509-L520.
172. Takeya R, Ueno N, Kami K, Taura M, Kohjima M, Izaki T, Nunoi H, and Sumimoto H (2003) Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 278:25234-25246.
173. Tamura M, Shiozaki I, Ono S, Miyano K, Kunihiro S, and Sasaki T (2007) p40phox as an alternative organizer to p47phox in Nox2 activation: a new mechanism involving an interaction with p22phox. FEBS Lett 581:4533-4538.
174. Taylor RM, Baniulis D, Burritt JB, Gripentrog JM, Lord CI, Riesselman MH, Maaty WS, Bothner BP, Angel TE, and Dratz EA et al. (2006) Analysis of human phagocyte flavocytochrome b(558) by mass spectrometry. J Biol Chem 281:37045-37056.
175. Taylor RM, Burritt JB, Baniulis D, Foubert TR, Lord CI, Dinauer MC, Parkos CA, and Jesaitis AJ (2004) Site-specific inhibitors of NADPH oxidase activity and structural probes of flavocytochrome b: characterization of six monoclonal antibodies to the p22phox subunit. J Immunol 173:7349-7357.
176. Taylor WR, Jones DT, and Segal AW (1993) A structural model for the nucleotide binding domains of the flavocytochrome b-245 beta-chain. Protein Sci 2:1675-1685.
177. Tickner J, Fan LM, Du J, Meijles D, and Li JM (2011) Nox2-derived ROS in PPARγ signaling and cell-cycle progression of lung alveolar epithelial cells. Free Radic Biol Med 51:763-772.
178. To EE, Broughton BR, Hendricks KS, Vlahos R, and Selemidis S (2014) Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages. Free Radic Res 48:940-947.
179. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solórzano A, Swayne DE, Cox NJ, Katz JM, Taubenberger JK, and Palese P et al. (2005) Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310:77-80.
180. Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335-344.
181. Ueyama T, Lekstrom K, Tsujibe S, Saito N, and Leto TL (2007) Subcellular localization and function of alternatively spliced Noxo1 isoforms. Free Radic Biol Med 42:180-190.
182. Vásquez-Vivar J and Kalyanaraman B (2000) Generation of superoxide from nitric oxide synthase. FEBS Lett 481:305-306.
183. Vásquez-Vivar J, Kalyanaraman B, Martásek P, Hogg N, Masters BSS, Karoui H, Tordo P, and Pritchard KA, Jr (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95:9220-9225.
184. Vignais PV (2002) The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59:1428-1459.
185. Vlahos R, Stambas J, Bozinovski S, Broughton BR, Drummond GR, and Selemidis S (2011) Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog 7:e1001271.
186. Vlahos R, Stambas J, and Selemidis S (2012) Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol Sci 33:3-8.
187. Wallach TM and Segal AW (1997) Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro. Biochem J 321:583-585.
188. Werner E (2004) GTPases and reactive oxygen species: switches for killing and signaling. J Cell Sci 117:143-153.
189. Wingler K, Wünsch S, Kreutz R, Rothermund L, Paul M, and Schmidt HH (2001) Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 31:1456-1464.
190. Wittwer J and Hersberger M (2007) The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 77:67-77.
191. World Health Organization (WHO) (2009) Influenza, Geneva: WHO.Seasonal.
192. Yang S, Madyastha P, Bingel S, Ries W, and Key L (2001) A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276:5452-5458.
193. Yao H, Edirisinghe I, Yang SR, Rajendrasozhan S, Kode A, Caito S, Adenuga D, and Rahman I (2008) Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice. Am J Pathol 172:1222-1237.
194. Yatmaz S, Seow HJ, Gualano RC, Wong ZX, Stambas J, Selemidis S, Crack PJ, Bozinovski S, Anderson GP, and Vlahos R (2013) Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation. Am J Respir Cell Mol Biol 48:17-26.
195. Yuzawa S, Ogura K, Horiuchi M, Suzuki NN, Fujioka Y, Kataoka M, Sumimoto H, and Inagaki F (2004) Solution structure of the tandem Src homology 3 domains of p47phox in an autoinhibited form. J Biol Chem 279:29752-29760.
196. Zangar RC, Davydov DR, and Verma S (2004) Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 199:316-331.
197. Zhu Y, Marchal CC, Casbon A-J, Stull N, von Löhneysen K, Knaus UG, Jesaitis AJ, McCormick S, Nauseef WM, and Dinauer MC (2006) Deletion mutagenesis of p22phox subunit of flavocytochrome b558: identification of regions critical for gp91phox maturation and NADPH oxidase activity. J Biol Chem 281:30336-30346.